Tradestie Institutional Equity Comparison Engine

KMTS vs FEMY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KMTS Overall Edge

KMTS Captures Institutional Edge (1โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Kestra Medical Technologies, Ltd. Common Stock (KMTS) driven by superior Growth & Margin while FEMY counters with relative strength in Momentum & Technical. Fundamentally, KMTS trades at N/M Forward P/E with -134.5% operating margin (+59.9% YoY revenue) versus FEMY at N/M Forward P/E and -763.9% operating margin (-18.9% YoY). In options structure, KMTS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against FEMY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
KMTS N/M vs FEMY N/M Fwd P/E
Growth & Margin Winner KMTS
Op Margin -134.5% vs -763.9% ยท YoY +59.9% vs -18.9%
Momentum & Technical Winner FEMY
1Y +12.3% vs +54.8% ยท 52W Pos 73% vs 17%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
KMTS NASDAQ
Kestra Medical Technologies, Ltd. Common Stock
Surgical & Medical Instruments & Apparatus
$27.97
-2.34% 1D
Market Cap $1.7B
1M Return +2.68%
1Y Return +12.28%
Forward P/E N/M
Unified AI Score
43.8 / 100 HOLD
Tech 21.0 Fund 39.0 Flow 50.0 Mom 40.0
FEMY NASDAQ
Femasys Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.28
-9.86% 1D
Market Cap $11.9M
1M Return -22.42%
1Y Return +54.78%
Forward P/E N/M
Unified AI Score
52.6 / 100 HOLD
Tech 61.0 Fund 62.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: KMTS +12.28% FEMY +54.78% Spread: +42.5 pp (FEMY Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period KMTS Revenue FEMY Revenue KMTS Op. Margin FEMY Op. Margin Margin Edge
FY2020 N/A $0M N/A -668.0% FEMY
FY2021 N/A $0M N/A -706.7% FEMY
FY2022 N/A $0M N/A -961.7% FEMY
FY2023 N/A $0M N/A -1353.4% FEMY
FY2024 $30M $0M -305.8% -1091.8% KMTS
FY2025 $60M $0M -177.8% -767.0% KMTS
FY2026 $100M N/A -141.6% N/A KMTS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: KMTS (6) vs FEMY (2)
Institutional Metric KMTS FEMY Criterion Row Winner
Market Capitalization Scale $1.7B $11.9M Larger Scale KMTS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +59.9% -18.9% Higher Growth KMTS
Operating Margin (TTM) Profitability -134.5% -763.9% Higher Margin KMTS
Net Profit Margin Profitability -140.4% 0.0% Higher Margin FEMY
Return on Equity (ROE) Capital Efficiency -73.7% -425.0% Higher ROE KMTS
52-Week Range Position Momentum 73% ($17โ€“$32) 17% ($0โ€“$6) Stronger Trend KMTS
Beta / 30D Volatility Risk Regime 1.84ฮฒ ยท 63% Vol 4.01ฮฒ ยท 72% Vol Lower Realized Risk KMTS
Unified Institutional Score Composite Signal 43.8 / 100 (HOLD) 52.6 / 100 (HOLD) Higher Composite FEMY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full KMTS vs FEMY Buy Guide
KMTS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live KMTS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FEMY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FEMY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither KMTS nor FEMY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.